The first case of NDM-1 was discovered in New Delhi, India (in 2009), thus the name New Delhi Metallo-beta-lactamase or NDM-1. The typical antibiotics used to treat such beta-lactamase bacteria are called carbapenems, however, NDM-1 bacteria are resistant to such antibiotics.
While many in the news are calling NDM-1 a “superbug” given its resistance to carbapenems, its incidence is still quite rare. Only one reported death has been attributed to NDM-1 with many of the cases coming from patients hospitalized overseas, particularly in India and Pakistan.
In March, 2009 the CDC published its “Guidance for Control of Infections with Carbapenem-Resistant or Carbapenemase-Producing Enterobacteriaceae in Acute Care Facilities” to help prevent transmission.
What you need to know:
- It is linked to people who have had surgeries in India and Pakistan mostly.
- There have been some cases in the U.K. as a result of people who had surgeries in India or Pakistan and were subsequently hospitalized in the U.K.
- It can be any bug, so in other words, there are no specific symptoms to look out for. It can be a GI bug, or a skin bug, or a respiratory bug.
- This particular enzyme is still rare among bacteria in the U.S.
- Prevention: the usual, most effective way: GOOD HYGIENE!!!!!